Chong Kun Dang Pharmaceutical: all 299 studies

Page 3 of 3. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase InhibitorsCompletedNCT02977065Phase 2
• Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult VolunteersCompletedNCT02916901Phase 1
• Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519CompletedNCT02894541Phase 1
• Evaluate the Drug-drugs Interaction Between Lobeglitazone and EmpagliflozinStatus unknownNCT02854748Phase 1
• CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)CompletedNCT02827890Phase 1
• CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)CompletedNCT02824874Phase 1
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - BCompletedNCT02811731Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 TabletStatus unknownNCT02805738Phase 3
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - ACompletedNCT02801526Phase 1
• Study to Evaluate the Efficacy and Safety of CKD-350Status unknownNCT02777723Phase 3
• Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519CompletedNCT02753504Phase 1
• A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male VolunteersCompletedNCT02685774Phase 1
• Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCompletedNCT02651870Phase 3
• A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337CompletedNCT02651753Phase 1
• Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male VolunteersCompletedNCT02648854Phase 1
• Study to Compare the Safety and Pharmacokinetics of CKD-397CompletedNCT02645890Phase 1
• A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male VolunteersCompletedNCT02627027Phase 1
• Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.CompletedNCT02623868Phase 1
• A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male SubjectsCompletedNCT02615782Phase 1
• Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® TabletCompletedNCT02589457Phase 1
• Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B PatientsStatus unknownNCT02588937Phase 4
• CKD-330 Phase 3 Trial in Amlodipine Non-responderCompletedNCT02586311Phase 3
• A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male VolunteersCompletedNCT02565368Phase 1
• Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate DrugsCompletedNCT02548286Phase 1
• Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately ControlledStatus unknownNCT02526875Phase 4
• CKD-391 Pharmacokinetic Study Phase ICompletedNCT02501200Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-342CompletedNCT02498509Phase 3
• Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)CompletedNCT02484482Phase 1
• Efficacy and Safety of Lobeglitazone Versus SitagliptinStatus unknownNCT02480465Phase 4
• CKD-391 Pharmacokinetic StudyCompletedNCT02461004Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-391CompletedNCT02451098Phase 3
• CKD-337(2) Drug-drug Interaction StudyCompletedNCT02422030Phase 1
• CKD-828 (80/5mg) Pharmacokinetic StudyCompletedNCT02358824Phase 1
• Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis PatientsCompletedNCT02356679Phase 4
• Tacrobell tab_Phase1_PKCompletedNCT02336854Phase 1
• CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy VolunteersCompletedNCT02288338Phase 1
• CKD-828 (80/5mg) Pharmacokinetic StudyCompletedNCT02250833Phase 1
• CKD-397 Drug-drug Interaction Study (A)CompletedNCT02247518Phase 1
• CKD-397 Drug-drug Interaction Study (B)CompletedNCT02247505Phase 1
• The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan MonotherapyCompletedNCT02231788Phase 4
• A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionStatus unknownNCT02206165Phase 2
• Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)CompletedNCT02186496Phase 1
• Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519CompletedNCT02156544Phase 1
• CKD-337 Drug Interaction StudyCompletedNCT02066207Phase 1
• CKD-330 Drug-Drug Interaction Study (Candesartan)CompletedNCT02064621Phase 1
• CKD-330 Drug-Drug Interaction Study (Amlodipine)CompletedNCT02064556Phase 1
• CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)CompletedNCT02047175Phase 1
• Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function SubjectsCompletedNCT02007941Phase 1
• Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)Status unknownNCT02005757Phase 2
• A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic FunctionCompletedNCT02005744Phase 1
• Drug-drug Interaction Study(Lobeglitazone, Warfarin)CompletedNCT02002611Phase 1
• Efficacy and Safety of TELMINUVO to Stage 2 HypertensionStatus unknownNCT01983735Phase 3
• Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With AtorvastatinStatus unknownNCT01956201Phase 3
• Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mgCompletedNCT01910077Not applicable
• The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERDCompletedNCT01860482Phase 4
• Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant PatientsCompletedNCT01842269Phase 4
• Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.CompletedNCT01842256Phase 1
• Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipineCompletedNCT01842230Phase 1
• Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mgStatus unknownNCT01819870Phase 1
• The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)Status unknownNCT01766518Phase 4
• The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)TerminatedNCT01766505Phase 4
• Efficacy and Safety of Imotun Capsule in Osteoarthritis of the KneeCompletedNCT01756937Phase 4
• Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential HypertensionCompletedNCT01756430Phase 3
• Efficacy and Safety Study of Tacrobell to Treat Rheumatoid ArthritisCompletedNCT01746680Phase 4
• The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the KneeCompletedNCT01743287Phase 4
• Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male VolunteersCompletedNCT01685671Phase 1
• Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male VolunteersCompletedNCT01684605Phase 1
• To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureCompletedNCT01682564Phase 4
• Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate CombinationCompletedNCT01663038Phase 1
• Efficacy and Safety of CKD-828 to Stage 2 HypertensionCompletedNCT01634295Phase 3
• Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb TrialCompletedNCT01630018Phase 2
• Safety and Pharmacokinetic Profile of CKD-581CompletedNCT01580371Phase 1
• Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid CancersCompletedNCT01560325Phase 1
• CKD-828 S-Amlodipine Non-Responder TrialCompletedNCT01501253Phase 3
• A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung CancerCompletedNCT01497873Phase 2
• Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd TrialCompletedNCT01496261Phase 1
• CKD-828 Telmisartan Non-Responder TrialCompletedNCT01426100Phase 3
• Evaluating Dose-proportionality of Dilatrend Suspended-Release CapsuleCompletedNCT01369472Phase 1
• CKD-828 Drug Interaction Study (S-amlodipine)CompletedNCT01356043Phase 1
• CKD-828 Drug Interaction Study (Telmisartan)CompletedNCT01356017Phase 1
• CKD-828(80/2.5mg) Pharmacokinetic Study_2ndCompletedNCT01352689Phase 1
• Drug-drug Interaction Study(CKD-501, Amlodipine)CompletedNCT01341392Phase 1
• A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male VolunteersCompletedNCT01340248Phase 1
• CKD-828 (40/5mg) Pharmacokinetic StudyCompletedNCT01340131Phase 1
• Drug-drug Interaction Study (CKD-501, Ketoconazole)CompletedNCT01330563Phase 1
• Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy SubjectsCompletedNCT01270984Phase 1
• CKD-828(80/2.5mg) Pharmacokinetic StudyCompletedNCT01246193Phase 1
• The Pharmacokinetic Interaction Between CKD-501 and SulfonylureaCompletedNCT01133431Phase 1
• CKD-828 Primary Hypertension Trial(Dose-selection)CompletedNCT01128322Phase 2
• Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to MetforminCompletedNCT01106131Phase 3
• The Effect of Food on the Pharmacokinetic Characteristics of CKD-501CompletedNCT01071720Phase 1
• Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes MellitusCompletedNCT01030679Phase 2
• Dyslipidemia in Cardiovascular DiseaseCompletedNCT01029522Phase 4
• Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid CancersCompletedNCT01028859Phase 1
• Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With ChemotherapyCompletedNCT01022671Phase 2
• Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid CancerCompletedNCT01019941Phase 1
• Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) TabletCompletedNCT01016626Phase 1
• Drug Interaction Between CKD-501 and MetforminCompletedNCT01005160Phase 1
• An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes MellitusCompletedNCT01001611Phase 3

← Chong Kun Dang Pharmaceutical overview and focus areas